In an era defined by environmental challenges and a greater emphasis on corporate responsibility, the biotech industry is at a crossroads where sustainability is not just a choice but an imperative. With an increasing number of companies committing to environmental, social, and governance (ESG)
Amidst rising global environmental challenges, the world is beginning to recognize synthetic biology as a pivotal tool in biodiversity conservation. This change marks significant progress within the Convention on Biological Diversity (CBD) framework, which originally viewed biotechnological
In the rapidly evolving field of bioengineering, collaboration stands at the forefront, driving transformative advancements that hold the potential to address significant health and environmental challenges. Bioengineering, or biomedical engineering, combines engineering principles with biological
In a groundbreaking move to push the boundaries of sustainable practices, the National Science Foundation has awarded $1.9 million to the Samueli School of Engineering at UCLA. This grant forms part of a larger $7.5 million initiative aimed at revolutionizing chemical manufacturing by employing
Ivan Kairatov, a renowned expert in biopharma, is at the forefront of innovation in the biotechnology and biomanufacturing industry. With extensive experience in research and development, he has played a pivotal role in advancing sustainable solutions within the field. Today, Ivan shares insights
In the ever-evolving landscape of medical science, the breast cancer therapeutics market stands out as a beacon of innovation and advancement. Progress in targeted therapies, immunotherapy, and precision medicine has significantly propelled market growth as breast cancer continues affecting
